Physician profile
John A Lovier, JR.
NPI 1386614436
$1,024.60
in general payments reported to CMS, 2019-2025
17 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.15 · 2021: $46.79 · 2022: $56.96 · 2023: $332 · 2024: $261 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $303.74 | 2023-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $139.66 | 2025 | Zurzuvae |
| Pfizer INC. | $135.29 | 2022-2024 | |
| Baxter Healthcare | $85.50 | 2021-2023 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $60.64 | 2025 | |
| Agile Therapeutics, INC. | $46.09 | 2023-2024 | Twirla |
| Organon LLC | $38.55 | 2023-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $31.94 | 2023-2024 | Myfembree |
| Abbvie INC. | $31.52 | 2024 | |
| Merck Sharp & Dohme LLC | $29.31 | 2024 | Gardasil, Gardasil 9 |
| Axonics, INC. | $24.73 | 2023 | Bulkamid, Axonics |
| Hologic Sales and Service, LLC | $20.48 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Mylan Pharmaceuticals INC. | $19.99 | 2021 | |
| Pharmacosmos Therapeutics INC. | $16.33 | 2023 | Monoferric |
| Novo Nordisk INC | $15.15 | 2023 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $14.53 | 2021 | |
| Allergan, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lovier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.